Knowledge graph · Drug
Tositumomab
monoclonal antibody
- Identifier
- CI-DRUG-00000707
- Entity page
- /drug/tositumomab ↗
- Edges
- 14
- Neighbours
- 7 cancers1 genes3 trials1 approvals
- Drawn
- 12 of 12 neighbours (cap 60); table lists every fetched edge
Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.
Most connectedLung Non-Small Cell Carcinoma 3,147Malignant Colorectal Neoplasm 1,866ABL1 298EGFR 276Imatinib 450Dasatinib 321
Neighbourhood
Radial view
Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.
Edges
Every edge, grouped by relationship
Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.
| Relationship | Neighbour | Direction | Evidence level | Cancer context | Support | Claim | Source | Expand |
|---|---|---|---|---|---|---|---|---|
| Tositumomab approved for …APPROVED_FORderived1 of 1 | ||||||||
| → approved for | Health Canada · CA · 2006Marketed in Canada as BEXXAR THERAPY (DIN 02270471) under ATC V10XA53 TOSITUMOMAB/IODINE (131 I) TOSITUMOMAB. Indications are not published in the Drug Product Database — see the Health Canada Product Monograph. Health Canada (CA) · withdrawn · 2006-04-10 · Marketed in Canada as BEXXAR THERAPY (DIN 02270471) under ATC V10XA53 TOSITUMOMAB/IODINE (131 I) TOSITUMOMAB. Indications are not published… | — | withdrawn | not mapped | 1 | Regulatory | health-canada-dpd | open ↗ |
| Tositumomab targets … | ||||||||